“…It is well recognised that alveolar macrophages and their precursors, circulating monocytes, play a key role in airway inflammatory diseases ( Arm & Lee, 1992 ; Spina et al ., 1998a ; Barnette & Underwood, 2000 ; Jeffery, 2000 ; Giembycz, 2002 ; Barnes, 2003 ) and we have set out here using the human U937 cell line to define the PDE4 isoforms expressed in both their monocytic and macrophage‐like states ( Hass et al ., 1989 ; Twomey et al ., 1993 ; Kuroda et al ., 1997 ; Fukunaga & Tsuruda, 2001 ; Matheson et al ., 2002 ). Intriguingly, it has been shown ( Tenor et al ., 1995 ; Gantner et al ., 1997 ; Bender et al ., 2004 ) that the in vitro differentiation of both peripheral blood‐derived and alveolar monocytes to macrophages leads to a marked downregulation of PDE4 activity, concomitant with an upregulation of PDE3 and PDE1 activities.…”